louisiana semaglutide gi obstruction lawsuit glp-1 diarrhea law firm in diarrhea law firm in louisiana kentucky semaglutide gastrointestinal lawyer Wegovy® Lawsuit-150cent louisiana semaglutide gastrointestinal obstruction class
Description
Wegovy and Ozempic have helped millions of people lose weight in 2021 the participants of a landmark clinical trial lost on average 15% of their body weight over the course of 68 weeks
In the tirzepatide trial, participants lost an average of 6.9% of their weight after 12 weeks, while retatrutide participants lost 7.2% at the lowest dose after 24 weeks
Food and Drug Administration in 2017 to treat type 2 diabetes, was recently OK'd to also help reduce risks linked to chronic kidney disease, or CKD
Supports healthy blood glucose regulation through improved glucose-dependent insulin signaling
